Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients With Spinal Muscular Atrophy (SMA)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
A Study of CK-2127107 in Patients With Spinal Muscular Atrophy
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients With Spinal Muscular Atrophy (SMA)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Southwest Autism Research and Resource Center (SARRC)
mi
from
Phoenix, AZ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Southwest Autism Research and Resource Center (SARRC)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.)
mi
from
Little Rock, AR
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.)
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
NRC Research Institute
mi
from
Orange, CA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Mind Institute (Univ.of California, Davis)
mi
from
Sacramento, CA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Mind Institute (Univ.of California, Davis)
mi
from
Sacramento, CA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of California, UCSF
mi
from
San Francisco, CA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of California, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
APG Research, LLC
mi
from
Orlando, FL
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
APG Research, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
LSU Health Sciences Center
mi
from
Shreveport, LA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
LSU Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Detroit Clinical Research Center, P.C.
mi
from
Bingham Farms, MI
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Detroit Clinical Research Center, P.C.
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Montefiore Med.Cneter, Autism & Obsessive Compulsive Spectrum Program
mi
from
Bronx, NY
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Montefiore Med.Cneter, Autism & Obsessive Compulsive Spectrum Program
mi
from
Bronx, NY
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Richmond Behavioral Associates
mi
from
Staten Island, NY
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Duke Center for Autism and Brain Development
mi
from
Durham, NC
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Duke Center for Autism and Brain Development
mi
from
Durham, NC
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Autism Center
mi
from
Cleveland, OH
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Autism Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
mi
from
Warwick, RI
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Universtiy Med.Center-Treatment&Research Inst. For Asd
mi
from
Nashville, TN
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Universtiy Med.Center-Treatment&Research Inst. For Asd
mi
from
Nashville, TN
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of Texas, Houston-Behavioral & Biomedical Sciences
mi
from
Houston, TX
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of Texas, Houston-Behavioral & Biomedical Sciences
mi
from
Houston, TX
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Carilion Clinic-Virginia Tech, Carilion School of Medicine
mi
from
Roanoke, VA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Carilion Clinic-Virginia Tech, Carilion School of Medicine
mi
from
Roanoke, VA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of Arizona, Pediatrics Multidisciplinary Research Unit
mi
from
Tucson, AZ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of Arizona, Pediatrics Multidisciplinary Research Unit
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
IMMUNOe Research Centers
mi
from
Centennial, CO
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
IMMUNOe Research Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Yale Child Study Center
mi
from
New Haven, CT
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Research Institute of Deaconess Clinic
mi
from
Newburgh, IN
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Research Institute of Deaconess Clinic
mi
from
Newburgh, IN
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of NJ
mi
from
Voorhees, NJ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of NJ
mi
from
Voorhees, NJ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
NeuroScience, Inc.
mi
from
Herndon, VA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of Virginia, Dept. of Psychiatry and Neurobehavioral Sciences
mi
from
Charlottesville, VA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of Virginia, Dept. of Psychiatry and Neurobehavioral Sciences
mi
from
Charlottesville, VA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
The Segal Institute of Clinical Research
mi
from
North Miami, FL
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Children'S Specialized Hospital
mi
from
Egg Harbor Township, NJ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Children'S Specialized Hospital
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Medical Group-Lake Mary Pediatrics
mi
from
Orange City, FL
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Medical Group-Lake Mary Pediatrics
mi
from
Orange City, FL
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Children's Specialized Hospital
mi
from
Toms River, NJ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Children's Specialized Hospital
mi
from
Toms River, NJ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Focus Center of Clinical Research
mi
from
Clinton, UT
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Focus Center of Clinical Research
mi
from
Clinton, UT
Click here to add this to my saved trials
Prevention of Delirium in Inpatients Utilizing Melatonin
Prevention of Delirium in Inpatients Utilizing Melatonin
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital—Saint Raphael Campus
mi
from
New Haven, CT
Prevention of Delirium in Inpatients Utilizing Melatonin
Prevention of Delirium in Inpatients Utilizing Melatonin
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital—Saint Raphael Campus
mi
from
New Haven, CT
Click here to add this to my saved trials
Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury
Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Neurotrauma Clinical Trials Center
mi
from
Pittsburgh, PA
Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury
Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Neurotrauma Clinical Trials Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
Parkinson's Disease and Movement Disorders Center of Boca Raton
mi
from
Boca Raton, FL
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
Parkinson's Disease and Movement Disorders Center of Boca Raton
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical School
mi
from
Minneapolis, MN
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical School
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
University of California San Francisco Medical Center-Parnassus
mi
from
San Francisco, CA
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco Medical Center-Parnassus
mi
from
San Francisco, CA
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
University of Florida College of Medicine
mi
from
Gainesville, FL
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated:  12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
Status: Enrolling
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Examination of Balance, Vestibular, and Ocular Functions and Activity Following Concussion
A Longitudinal Examination of Dynamic Balance Control, Vestibular/Ocular Motor Function, and Activity Participation Following Concussion
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Examination of Balance, Vestibular, and Ocular Functions and Activity Following Concussion
A Longitudinal Examination of Dynamic Balance Control, Vestibular/Ocular Motor Function, and Activity Participation Following Concussion
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Status: Enrolling
Updated:  12/31/1969
Seattle Children'S Research Institute
mi
from
Seattle, WA
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Status: Enrolling
Updated: 12/31/1969
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Status: Enrolling
Updated:  12/31/1969
University of Puget Sound
mi
from
Tacoma, WA
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Status: Enrolling
Updated: 12/31/1969
University of Puget Sound
mi
from
Tacoma, WA
Click here to add this to my saved trials